Core Viewpoint - H&H International Holdings (01112) has shown strong revenue growth in Q3 2025, with a year-on-year increase of 28.5%, leading to a positive market response with a stock price increase of 5.15% [1] Group 1: Financial Performance - For the first three quarters of 2025, H&H International Holdings reported a revenue of 10.81 billion yuan, reflecting a year-on-year growth of 12% [1] - In Q3 2025, the company achieved a revenue of 3.79 billion yuan, which is a 28.1% increase compared to the same quarter last year [1] - The company's revenue growth is primarily driven by the strong performance of its infant formula segment, which exceeded market expectations [1] Group 2: Business Segments - The company's ANC (Adult Nutrition Category) business is expanding its online channels and overseas markets, maintaining its industry-leading position [1] - The BNC (Baby Nutrition Category) business is showing continuous improvement, with a strong growth in ultra-premium infant formula, gaining market share despite industry challenges [1] - The PNC (Personal Nutrition Category) is advancing the high-end process in the Chinese market and global layout, with expectations for continued improvement in internal profits [1] Group 3: Future Outlook - The company is expected to achieve a high single to low double-digit revenue growth for the full year, with all three business segments maintaining a positive growth trend [1] - The ANC segment is projected to achieve a year-on-year growth in the mid to high single digits, while the BNC segment is expected to grow over 20% year-on-year [1] - The PNC segment is anticipated to see a low double-digit year-on-year growth, with the company maintaining a healthy profit margin and optimizing financial costs [1]
港股异动 | H&H国际控股(01112)涨超5% 三季度婴配奶粉增长超预期 机构预计公司利润...